Microsoft word - domperidone px handout_june2012.doc
Herzl Family Practice Centre, Goldfarb Breastfeeding Clinic Domperidone Patient Handout What is domperidone?
Domperidone is a pill that can increase breastmilk by increasing your levels of prolactin
(the hormone responsible for milk production).
This pill was originally developed for stomach problems such as reflux and nausea.
However, it is now being used widely in breastfeeding mothers.
It is an “off label use” medication when used for lactation. Higher doses are used for lactation then for its indicated gastrointestinal use. Who needs it?
1. Domperidone is not for everyone. There are specific reasons for this medication.
2. If you feel you do not have enough milk, you should first see a lactation consultant and/or
3. It is important to try other ways of increasing milk supply first (without pills).
4. Other medical problems may need to be treated first. Blood tests may need to be done. Is domperidone safe?
Domperidone is the only breastmilk-increasing medication studied and shown to be
It has been used safely for many years in many developed countries including
Canada, Australia and European countries.
Domperidone has been approved by Health Canada for use in children and adults for stomachproblems. In fact, the dose received by the infant through breastmilk is far less than the dosegiven to children.
Herzl Family Practice Centre, Goldfarb Breastfeeding Clinic, Jewish General Hospital, Montreal, QC 2009, updated 2012
What to be careful about when taking domperidone:
Domperidone, like all medicine, may have side effects and risks. However, we believe thatbreastfeeding while on domperidone is a safer alternative than having to give increasing amountsof formula.
Domperidone is one of the many medications that can affect the electrical conduction of theheart. Health Canada endorsed a recent update on domperidone noting again the extremely rarerisk of cardiac side effects (arrhythmia or cardiac arrest) in patients taking higher doses ofdomperidone. If you experience chest pain or palpitations stop the medication and contact thebreastfeeding clinic. If the symptoms persist see a doctor immediately. There has never been adocumented case of cardiac problems associated with domperidone use in breastfeedingmedicine in Canada.
If you have had any of the following conditions, you should discuss this with a doctor beforestarting domperidone:
History of bowel or colon surgery. Gastrointestinal conditions causing problems with digestion or absorption. Heart conditions causing chest pain, shortness of breath, palpitations, fainting or dizzy
spells or if you have been diagnosed with having long QT waves.
A family history of heart problems, unexplained fainting or sudden death. History of heart surgery. A brain tumor (prolactinoma) causing increased prolactin.
Domperidone can interact with other medication. It is important that you tell your doctor orpharmacy you are taking domperidone before you are given any medication. Medications that may interact with domperidone:
Medications used to treat fungal infections or thrush, i.e. fluconazole (Diflucan)
Some antibiotics, i.e. ciprofloxacin (Cipro), levofloxacin (Levaquin), erythromycin,
Grapefruit and its juice (and possibly grapefruit seed extract).
Some antidepressants, i.e. amitriptyline (Elavil), nortriptyline (Aventyl), fluoxetine
(Prozac), paroxetine (Paxil), sertraline (Zoloft), citalopram (Celexa), andflovoxamine (Luvox).
Lithium (absolute contraindication).
Some HIV medication (such as ritonavir (Norvir/Kaletra ))
Some antipsychotics (such as thioridazine (Mellaril) and mesoridazine (Serentil)).
Herzl Family Practice Centre, Goldfarb Breastfeeding Clinic, Jewish General Hospital, Montreal, QC 2009, updated 2012
Some anti-arrhythmics: Type IA (quinidine, procainamide, disopyramide (Rythmodan ,
Rythmodan LA ), types II and III solatol (Solatol , Sotacor ) and type III ( amiodarone(Cordarone , Amiodarone ), bretylium (Bretylate )). How to take domperidone:
Usually, you will be asked to start domperidone at a dose of 10 mg (or 1 pill) 4 times a
day. The maximum dose is 30 mg (3 pills) 4 times a day.
You may feel an increase in milk production anywhere from 2 -3 days to 2-3 weeks after
Domperidone is a long-term medication. You have to take it continuously for at least 3
to 8 weeks for it to have its full effect. Most mothers take it for a few months, and stopgradually after discussion with their health professional.
It is important to continue pumping and putting the baby to the breast as often as possible
stimulation. If the breasts are not stimulated, domperidone will not be able to do its jobas well.
You may continue taking herbs along with domperidone, if you feel that the herbs are
Side effects:
Side effects are not very common, and usually improve after a week of taking domperidone.
Headache Dry mouth Dizziness Diarrhea (or change in bowel movements), abdominal cramps Increased appetite Weight gain Fatigue
The information contained in this patient handout is a suggestion only, and is not a substitute for consultation with ahealth professional or lactation specialist. This handout is the property of the author(s) and the GoldfarbBreastfeeding Clinic. No part of this handout can be changed or modified without permission from the author andthe Goldfarb Breastfeeding Clinic. This handout may be copied and distributed without further permission on thecondition that it is not used in any context in which the International Code for the Marketing of BreastmilkSubstitutes is violated. For more information, please contact the Goldfarb Breastfeeding Clinic, Herzl FamilyPractice Centre, Jewish General Hospital, Montreal, Quebec, Canada. 2012
Herzl Family Practice Centre, Goldfarb Breastfeeding Clinic, Jewish General Hospital, Montreal, QC 2009, updated 2012
Medical Procedures and Relevant Information 1. Parents and participants should inform us of pertinent health-related information on the MEDICAL INFORMATION AND PERMISSION FOR MEDICAL TREATMENT FORM. 2. If parents wil be traveling while their son is in China, we need to know how they can be reached in case of emergency. Please enter the relevant information on the MEDICAL INFORMATION AND PERMI
CORRESPONDENCE Ann Thorac Surg 2012;94:1782–9 References Davide Pacini, MD 1. Parolari A, Pesce LL, Pacini D, et al. Monzino Research Department of Cardiac Surgery Group on Cardiac Surgery Outcomes. Risk factors for S Orsola-Malpighi Hospital perioperative acute kidney injury after adult cardiac sur- University of Bologna gery: role of perioperative ma